US Stock MarketDetailed Quotes
ORTX Orchard Therapeutics
- 0.0000
- 0.00000.00%
Close Nov 27 09:30 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.0000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)22.76MShares16.720052wk High0.00P/B0Float Cap16.180052wk Low--Dividend TTM11.73MShs Float216.4000Historical High--Div YieldTTM0.00%Amplitude3.6010Historical Low--Avg Price1Lot Size
Orchard Therapeutics Stock Forum
Sign in to post a comment
🗓️ Last week’s PDUFAs:
$Orchard Therapeutics (ORTX.US)$ (Kyowa Kirin): Approved 🎉
⇒ Lenmeldy (atidarsagene autotemcel)
⇒ early-onset MLD
⇒ BLA
⇒ PDUFA: 3/18/24
$Esperion Therapeutics (ESPR.US)$ : Approved 🎉
⇒ Nexletol (bempedoic acid) & Nexlizet (bempedoic acid and ezetimibe)
⇒ CV risk reduction, primary hyperlipidemia (HeFH)
⇒ sNDA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs:
$Merck & Co (MRK.US)$ : 🤔
⇒ Sotatercept
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24...
$Orchard Therapeutics (ORTX.US)$ (Kyowa Kirin): Approved 🎉
⇒ Lenmeldy (atidarsagene autotemcel)
⇒ early-onset MLD
⇒ BLA
⇒ PDUFA: 3/18/24
$Esperion Therapeutics (ESPR.US)$ : Approved 🎉
⇒ Nexletol (bempedoic acid) & Nexlizet (bempedoic acid and ezetimibe)
⇒ CV risk reduction, primary hyperlipidemia (HeFH)
⇒ sNDA
⇒ PDUFA: 3/31/24
📌 This week’s PDUFAs:
$Merck & Co (MRK.US)$ : 🤔
⇒ Sotatercept
⇒ Pulmonary arterial hypertension
⇒ BLA
⇒ PDUFA: 3/26/24...
10
1
$Orchard Therapeutics (ORTX.US)$ Orchard Therapeutics (ORTX), recently acquired by Kyowa Kirin (OTCPK:KYKOY), has set its newly FDA-approved rare disease therapy Lenmeldy at a wholesale price of $4.25M on Wednesday, making one-time gene therapy the world's costliest medicine.
Early this week, the FDA approved Lenmeldy as the first U.S. treatment for early-onset metachromatic leukodystrophy (MLD), a rare metabolic disorder.
The...
Early this week, the FDA approved Lenmeldy as the first U.S. treatment for early-onset metachromatic leukodystrophy (MLD), a rare metabolic disorder.
The...
2
4
$Orchard Therapeutics (ORTX.US)$ (Kyowa Kirin)
📣 Receives FDA Approval of Lenmeldy (atidarsagene autotemcel) 🎉
⇒ Only therapy for children with early-onset
metachromatic leukodystrophy (MLD) in US 👏
⇒ Lenmeldy known as Libmeldy in EU
📣 Receives FDA Approval of Lenmeldy (atidarsagene autotemcel) 🎉
⇒ Only therapy for children with early-onset
metachromatic leukodystrophy (MLD) in US 👏
⇒ Lenmeldy known as Libmeldy in EU
4
The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Eyenovia (EYEN.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $Mirum Pharmaceuticals (MIRM.US)$ $Madrigal Pharmaceuticals (MDGL.US)$ $Geron (GERN.US)$ $Bristol-Myers Squibb (BMY.US)$ $2seventy bio (TSVT.US)$ $Legend Biotech (LEGN.US)$ $OptiNose (OPTN.US)$ $Orchard Therapeutics (ORTX.US)$ $Merck & Co (MRK.US)$ $Akebia Therapeutics (AKBA.US)$ $AstraZeneca (AZN.US)$ $Liquidia (LQDA.US)$ $Esperion Therapeutics (ESPR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $BeiGene (BGNE.US)$
$Eyenovia (EYEN.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $Mirum Pharmaceuticals (MIRM.US)$ $Madrigal Pharmaceuticals (MDGL.US)$ $Geron (GERN.US)$ $Bristol-Myers Squibb (BMY.US)$ $2seventy bio (TSVT.US)$ $Legend Biotech (LEGN.US)$ $OptiNose (OPTN.US)$ $Orchard Therapeutics (ORTX.US)$ $Merck & Co (MRK.US)$ $Akebia Therapeutics (AKBA.US)$ $AstraZeneca (AZN.US)$ $Liquidia (LQDA.US)$ $Esperion Therapeutics (ESPR.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $BeiGene (BGNE.US)$
21
$Orchard Therapeutics (ORTX.US)$ Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
3 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE![]()
3 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE
2
Pre-Market Stock Movers
Gapping up
Shares of $UWM Holdings (UWMC.US)$ rose 4.3% in premarket trading after a BTIG upgrade to buy from neutral. BTIG said the valuation for the parent company of United Wholesale Mortgage does not reflect the upside from a potential stabilization in interest rates.
$Orchard Therapeutics (ORTX.US)$ soared more than 98% on news that the company would be acquired by Japanese pharmaceutical Ky...
Gapping up
Shares of $UWM Holdings (UWMC.US)$ rose 4.3% in premarket trading after a BTIG upgrade to buy from neutral. BTIG said the valuation for the parent company of United Wholesale Mortgage does not reflect the upside from a potential stabilization in interest rates.
$Orchard Therapeutics (ORTX.US)$ soared more than 98% on news that the company would be acquired by Japanese pharmaceutical Ky...
25
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
SpyderCall : Good stuff. As usual.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")